A modelling group convened by the World Health Organization and UNAIDS has estimated that if efforts are not made to mitigate and overcome interruptions in health services and supplies during the COVID-19 pandemic, a six-month disruption of antiretroviral therapy could lead to more than 500 000 extra deaths from AIDS-related illnesses, including

Between 1995 and 2018, the steepest decrease in new HIV infections among women occurred among adolescent girls and young women (aged 15 to 24 years)—a decline of 44% globally. Prevention programmes that focus on this age group are having an impact.

The Free to Shine campaign1 is an initiative of the African Union, the Organization of African First Ladies for Development (OAFLAD) and partners to address the growing complacency in the response to childhood HIV in Africa.

The Indian Council of Medical Research (ICMR) has obtained permission for “restricted use in public health emergency” of two second-line HIV medications for use against the novel coronavirus (nCoV)

The co-conveners of the Global HIV Prevention Coalition, UNAIDS and the United Nations Population Fund, have launched a new report on progress made in reducing new HIV infections across 28 countries that have been particularly affected by HIV.

The multiple deprivations affecting vulnerable populations are the greatest hurdle to achieving zero hunger. By directly addressing structural barriers, social protection can help WFP achieve its mandate on nutrition and food insecurity, and reach the most vulnerable, including people living with, at risk of1 and affected by HIV.

PARIS: HIV-related deaths last year fell to around 770,000 — some 33 percent lower than in 2010 — the United Nations said Tuesday, but warned that global efforts to eradicate the disease were stall

Global collaboration and sharing data on public health emergencies is important to fight the spread of infectious diseases.

Uíge — At least seventeen new positive HIV / AIDS cases were reported in the city of Uíge during the Unitel Health Fair.

MUMBAI: Pharma major Gilead Sciences has failed to deliver on promises to make an important drug available to patients suffering from a life-threatening HIV-related infection in certain developing

Pages